Improved Treatment and Monitoring of Alzheimer's Disease
NCT07135245
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
180
Enrollment
OTHER
Sponsor class
Conditions
Alzheimer Disease (AD)
Interventions
DRUG:
Semaglutide (Rybelsus®) combined with other interventions
OTHER:
Placebo
DRUG:
Semaglutide (Rybelsus®)
Sponsor
Rune Skovgaard Rasmussen
Collaborators
[object Object]